Key findings
- 29 DHSC medicine supply notices reached community pharmacy between January and September 2026. DHSC's own numbering hit MSN/2026/044 by 7 September.
- Fewer new notices than previous years: by 7 September the numbering had reached 44 in 2026, against 50 in 2025 and 93 in 2024.
- 13 of 29 (45%) passed their own estimated resupply date without the published notice confirming that supply had recovered.
- Heart and epilepsy medicines were hit hardest: 12 of 29 notices (41%).
- Some shortages run for years. Creon capsule protocols have been in force for 861 days; propranolol MR's estimate has moved from early March to November 2026.
- Patients searched MediWatch 34,649 times from 12 July to 30 September; monthly searches nearly tripled from July to September.
Headline numbers
MediWatch reads every DHSC medicine supply notification (MSN) that Community Pharmacy England publishes, and every NHSBSA Serious Shortage Protocol (SSP), twice a day. This study is what nine months of that record shows. Every notice is listed at the end, with a link to its source.
"Fewer new shortage notices than in 2024 or 2025 — but 45% of this year's passed their own resupply date without confirmation that stock had recovered, and some shortages have now run for more than two years."
MediWatch UK shortage tracker, data to 1 October 2026
New notices month by month
July was the busiest month of 2026, with six new notices, including sodium valproate (Epilim Chronosphere), nifedipine MR tablets, Fixapost eye drops and Voltarol Ophtha. April was the quietest, with one (ramipril 1.25mg capsules). Late August and early September brought a second cluster: Moviprep and Plenvu, venlafaxine 75mg, edoxaban 15mg, methylprednisolone, ramipril and lansoprazole orodispersible tablets.
New DHSC supply notices published for community pharmacy, 2026
By month of issue, January to September 2026
Show the data as a table
| Month | New notices |
|---|---|
| Jan | 3 |
| Feb | 5 |
| Mar | 2 |
| Apr | 1 |
| May | 2 |
| Jun | 2 |
| Jul | 6 |
| Aug | 4 |
| Sep | 4 |
Is 2026 worse than 2025?
Not on new notices. DHSC numbers its medicine supply notifications in sequence each year, so the highest reference issued by a given date is a clean year-on-year comparison. By 7 September, the numbering had reached:
Highest DHSC notice number issued by 7 September
MSN/YYYY/NNN reference reached by the same date each year
Counts only notices issued, not how long each one lasted. Source: MSN reference numbers in CPE-published notices.
Show the data as a table
| Year | Reference reached by 7 Sep | Of which published for community pharmacy and logged by MediWatch |
|---|---|---|
| 2024 | MSN/2024/093 | 52 |
| 2025 | MSN/2025/050 | 34 |
| 2026 | MSN/2026/044 | 29 |
So the flow of new shortages has slowed since the 2024 peak. That is not the same as shortages being solved. The problem in 2026 is duration: notices that outlive their estimates, and protocols renewed again and again.
The resupply dates that did not hold
Most supply notices give an estimated resupply date, such as "out of stock until mid-July 2026". The median estimate in 2026 notices was about 48 days (roughly seven weeks) after issue.
Of the 29 notices issued in 2026, 13 (45%) reached their estimated date without the published notice being updated to confirm that supply had recovered. A further 5 were not supply gaps at all (discontinuations and similar notices), and 11 were still active at our check.
What happened to the 29 notices issued in 2026
Status at MediWatch's check on 1 October 2026
"Unconfirmed" does not mean the medicine is still short. It means the official notice was never updated to say it is back. For a patient, that silence is the problem: you cannot tell from the notice whether to keep looking.
The clearest example is not even a 2026 notice. Propranolol 80mg and 160mg modified-release capsules came under DHSC notice MSN/2025/059 in November 2025, with supply expected in early March 2026. The estimate moved to July, then early August. On 10 September 2026, Community Pharmacy England reported that the SPS Medicines Supply Tool now showed November 2026: more than eight months later than the first estimate. Propranolol was the most-searched medicine on MediWatch this summer.
Which medicines were hit hardest
We grouped each 2026 notice by the condition the medicine treats. Heart and blood pressure medicines led, with seven notices: ramipril (twice), propafenone (twice), nifedipine, disopyramide and edoxaban. Epilepsy and neurology followed with five: sodium valproate (twice), phenobarbital, oxcarbazepine and the seizure rescue medicine midazolam (Epistatus).
New 2026 notices by therapeutic area
29 DHSC notices published for community pharmacy, January to September 2026
Grouping by MediWatch. Each notice is counted once, under the main condition the medicine treats.
Show the data as a table
| Therapeutic area | Notices |
|---|---|
| Heart & blood pressure | 7 |
| Epilepsy & neurology | 5 |
| Infections & wounds | 3 |
| Mental health & addiction | 3 |
| Digestive | 2 |
| Eye | 2 |
| Respiratory | 2 |
| Bladder & urology | 1 |
| Diabetes | 1 |
| Other (anti-sickness) | 1 |
| Pain | 1 |
| Steroids & immunology | 1 |
These are areas where switching is rarely simple. Epilepsy medicines in particular are often kept on the same product for consistency, so a supply gap can mean a specialist review rather than a pharmacy swap. See our heart medication and epilepsy medication shortage hubs.
The longest-running shortages
Some of the most important shortages started long before 2026. These were still in force at our check.
Longest-running shortages still in force
Days from first notice or protocol to 2 October 2026
Show the data as a table
| Medicine | Started | Days to 2 Oct 2026 | Basis |
|---|---|---|---|
| Creon 10000 and 25000 capsules (SSP060/SSP061) | 24 May 2024 | 861 | NHSBSA SSP, end date 2 Oct 2026 |
| Estradot 50/75/100 microgram patches (SSP079-081) | 19 Dec 2024 | 652 | NHSBSA SSP, end date 2 Oct 2026 |
| Quetiapine modified-release tablets (MSN/2025/006) | 10 Feb 2025 | 599 | DHSC MSN, still active |
| Tolterodine MR capsules (MSN/2025/031) | 20 May 2025 | 500 | DHSC MSN, still active |
| Abidec multivitamin drops (MSN/2025/044) | 16 Jul 2025 | 443 | DHSC MSN, still active |
| Propranolol 80mg/160mg MR capsules (MSN/2025/059) | 10 Nov 2025 | 326 | DHSC MSN; SPS estimate now November 2026 (CPE, 10 Sep 2026) |
- Creon 10000 and 25000 capsules (pancreatic enzymes for cystic fibrosis and pancreatic conditions): SSP060 and SSP061 started on 24 May 2024 and are listed with an end date of 2 October 2026. See Creon status.
- Estradot HRT patches: SSP079–SSP081 from 19 December 2024, also listed to 2 October 2026. See Estradot status.
- Quetiapine modified-release tablets: MSN/2025/006 since 10 February 2025; immediate-release tablets remain available. See quetiapine status.
What patients searched for
From 12 July to 30 September 2026, people searched MediWatch for a medicine 34,649 times. Searches grew every month, from 6,589 in the second half of July to 18,266 in September. 4,105 searches (11.8%) were for a medicine that had an active national notice at the time.
Medicine searches on MediWatch, 2026
Monthly searches (July counted from 12 July, when logging began)
Show the data as a table
| Month | Searches |
|---|---|
| Jul (from 12th) | 6,589 |
| Aug | 9,794 |
| Sep | 18,266 |
Most-searched medicines, 12 July to 30 September 2026
Searches on mediwatch.co.uk, by best-matching medicine
Show the data as a table
| Medicine | Searches |
|---|---|
| Propranolol | 1,973 |
| Estradot | 1,893 |
| Propafenone | 1,043 |
| Venlafaxine | 709 |
| Movicol | 432 |
| Ramipril | 406 |
| Quetiapine | 384 |
| Chlordiazepoxide | 165 |
| Levothyroxine | 164 |
| Elvanse | 162 |
The list maps closely onto the year's real problems: propranolol MR, Estradot, propafenone, venlafaxine, Movicol, ramipril and quetiapine.
People also used our pharmacy finder 31,497 times between 28 June and 30 September, for 4,294 different medicine names. Because no UK pharmacy publishes live prescription stock, none of those searches could be answered with confirmed stock; the finder lists nearby NHS pharmacies to phone. That gap, between what patients look for and what any public data can tell them, is one of the clearest findings in this study.
Every 2026 notice
All 29 DHSC medicine supply notifications published for community pharmacy from January to September 2026, with their status at our 1 October check.
| Notice | Issued | Medicine | Area | Status at 1 Oct |
|---|---|---|---|---|
| MSN/2026/001 | 12 Jan 2026 | Co-codamol 30mg/500mg tablets | Pain | Estimate passed, recovery unconfirmed |
| MSN/2026/002 | 15 Jan 2026 | Buprenorphine/naloxone (Suboxone® ) 2mg/500microgram and 8mg/2mg sublingual tablets | Mental health & addiction | Not a supply gap (e.g. discontinuation) |
| MSN/2026/004 | 28 Jan 2026 | Oxybutynin (Kentera® ) 3.9mg/24hours transdermal patches | Bladder & urology | Estimate passed, recovery unconfirmed |
| MSN/2026/007 | 10 Feb 2026 | Sulfadiazine silver (Flamazine®) 1% cream | Infections & wounds | Not a supply gap (e.g. discontinuation) |
| MSN/2026/010 | 16 Feb 2026 | Phenobarbital 30mg and 60mg tablets | Epilepsy & neurology | Estimate passed, recovery unconfirmed |
| MSN/2026/011 | 17 Feb 2026 | Propafenone (Arythmol® ) 150mg tablets | Heart & blood pressure | Estimate passed, recovery unconfirmed |
| MSN/2026/012 | 17 Feb 2026 | Sodium valproate (Epilim Chronosphere® ) 100mg modified-release granules sachets sugar free | Epilepsy & neurology | Estimate passed, recovery unconfirmed |
| MSN/2026/016 | 25 Feb 2026 | Co-trimoxazole 40mg/200mg/5ml oral suspension sugar free and Co-trimoxazole 80mg/400mg/5ml oral suspension | Infections & wounds | Estimate passed, recovery unconfirmed |
| MSN/2026/020 | 30 Mar 2026 | Cefixime (Suprax® ) 200mg tablets | Infections & wounds | Active |
| MSN/2026/021 | 30 Mar 2026 | Chlordiazepoxide 5mg and 10mg capsules | Mental health & addiction | Not a supply gap (e.g. discontinuation) |
| MSN/2026/022 | 23 Apr 2026 | Ramipril 1.25mg capsules | Heart & blood pressure | Estimate passed, recovery unconfirmed |
| MSN/2026/023 | 5 May 2026 | Midazolam (Epistatus® ) 7.5mg/0.75ml oromucosal solution pre-filled oral syringes sugar free | Epilepsy & neurology | Estimate passed, recovery unconfirmed |
| MSN/2026/024 | 18 May 2026 | Trurapi® (insulin aspart) 100units/ml solution for injection 3ml pre-filled Solostar pens | Diabetes | Estimate passed, recovery unconfirmed |
| MSN/2026/027 | 22 Jun 2026 | Propafenone (Arythmol® ) 150mg tablets | Heart & blood pressure | Estimate passed, recovery unconfirmed |
| MSN/2026/028 | 22 Jun 2026 | Disopyramide (Rythmodan® ) 100mg capsules and disopyramide (Rythmodan Retard® ) 250mg modified-release tablets | Heart & blood pressure | Active |
| MSN/2026/029 | 3 Jul 2026 | Oxcarbazepine 150mg tablets (Viatris) | Epilepsy & neurology | Estimate passed, recovery unconfirmed |
| MSN/2026/030 | 7 Jul 2026 | Sodium valproate (Epilim Chronosphere® ) 50mg, 250mg, and 500mg modified-release granules sachets sugar free | Epilepsy & neurology | Active |
| MSN/2026/031 | 9 Jul 2026 | Latanoprost 50micrograms/ml / Timolol 5mg/ml (Fixapost®) eye drops 0.2ml unit dose preservative free | Eye | Active |
| MSN/2026/032 | 14 Jul 2026 | Nabilone 1mg capsules | Other (anti-sickness) | Estimate passed, recovery unconfirmed |
| MSN/2026/033 | 23 Jul 2026 | Nifedipine 10mg, 20mg, 30mg and 60mg modified-release tablets | Heart & blood pressure | Active |
| MSN/2026/034 | 30 Jul 2026 | Voltarol® Ophtha and Voltarol® Ophtha Multidose eye drops | Eye | Active |
| MSN/2026/037 | 25 Aug 2026 | Moviprep® and Plenvu® oral powder sachets | Digestive | Active |
| MSN/2026/038 | 25 Aug 2026 | Beclometasone dipropionate (Clenil Modulite®) 50micrograms/dose and 250 micrograms/dose inhalers | Respiratory | Not a supply gap (e.g. discontinuation) |
| MSN/2026/039 | 25 Aug 2026 | Formoterol fumarate dihydrate (Atimos Modulite®) 12micrograms/dose inhaler | Respiratory | Not a supply gap (e.g. discontinuation) |
| MSN/2026/040 | 26 Aug 2026 | Venlafaxine 75mg immediate-release tablets | Mental health & addiction | Active |
| MSN/2026/041 | 1 Sept 2026 | Methylprednisolone (Medrone®) 100mg tablets | Steroids & immunology | Active |
| MSN/2026/042 | 1 Sept 2026 | Edoxaban (Lixiana®) 15mg tablets | Heart & blood pressure | Estimate passed, recovery unconfirmed |
| MSN/2026/043 | 7 Sept 2026 | Ramipril 1.25mg, 2.5mg, 5mg and 10mg capsules | Heart & blood pressure | Active |
| MSN/2026/044 | 7 Sept 2026 | Lansoprazole 15mg and 30mg orodispersible tablets | Digestive | Active |
Method and limitations
- Source. DHSC medicine supply notifications as published by Community Pharmacy England, and NHSBSA's Serious Shortage Protocol list, collected twice daily by MediWatch. Snapshot taken on 1 October 2026 (17:17 UTC); figures checked on 2 October 2026.
- Coverage. CPE publishes the notices relevant to community pharmacy. Some DHSC notices, mainly hospital-only products, are not included, which is why 29 notices are logged against a reference number of 44.
- "Estimate passed, recovery unconfirmed". The notice's own estimated date has passed and the published notice does not say supply has recovered. Updates can appear elsewhere, such as the login-only SPS Medicines Supply Tool, as happened with propranolol.
- Year-on-year. Based on the highest MSN reference number issued by 7 September each year, as seen in CPE-published notices.
- Searches. Aggregate counts of searches on mediwatch.co.uk, matched to a medicine name. No personal data is included, and no medicine with fewer than ten searches is named.
- Therapeutic areas. Assigned by MediWatch, one per notice.
Journalists and researchers: you are welcome to use these figures with a credit to "MediWatch UK shortage tracker" and a link to this page. For anything you need that is not here, contact us.
Questions people ask
How many medicine shortages has the UK had in 2026?
Between 1 January and 7 September 2026, DHSC's medicine supply notification reference numbers reached MSN/2026/044. 29 of those notices were published for community pharmacy by Community Pharmacy England and logged by MediWatch. The rest mainly concern hospital-only products.
Are UK medicine shortages getting worse in 2026?
On new notices, no. By 7 September DHSC's numbering had reached 44 in 2026, against 50 by the same date in 2025 and 93 in 2024. But many shortages last a long time: at our 1 October check, 20 notices and 9 Serious Shortage Protocols were active, some dating back to 2024.
Which medicines were hit hardest by shortages in 2026?
Heart and blood pressure medicines (7 of 29 notices, including ramipril, nifedipine, propafenone and edoxaban) and epilepsy and neurology medicines (5, including sodium valproate, phenobarbital and oxcarbazepine). Together that is 12 of 29.
What is the longest-running UK medicine shortage?
Among protocols still in force at our check, Creon 10000 and 25000 capsules: NHSBSA Serious Shortage Protocols SSP060 and SSP061 started on 24 May 2024 and run to 2 October 2026, 861 days. Quetiapine modified-release tablets have been under DHSC notice MSN/2025/006 since 10 February 2025.
Can I use these figures?
Yes. Please cite "MediWatch UK shortage tracker" and link to this page. The underlying notices are DHSC and NHSBSA publications; the counts, classifications and search figures are MediWatch's own analysis.
How was the data collected?
MediWatch reads Community Pharmacy England's shortage feed (which publishes DHSC medicine supply notifications) and NHSBSA's Serious Shortage Protocol list twice a day and stores each notice. Search figures are aggregate counts of searches on mediwatch.co.uk. No personal data is included.
Related pages
Live UK shortage tracker
Every active notice, updated twice daily.
NHS drug shortages list 2026
The full list, medicine by medicine.
Most commonly shorted medicines
Which medicines run short most often.
Heart medication shortages
The hardest-hit area in 2026.
Epilepsy medication shortages
Valproate, phenobarbital and more.
Our data sources
Where every number comes from.
Track your medicine
We'll email you only when this medicine's status actually changes — including when it's back in stock. Most weeks that's nothing, and that's good news. Your first 5 tracked medicines are free.
Track a medicine →Written by the MediWatch editorial team and checked against the official sources above on 2 October 2026. This page is information, not medical advice. Always follow your pharmacist, GP, specialist, NHS 111 or urgent-care advice for your own medicine. Report an accuracy issue.
This page was written by the MediWatch editorial team and checked for accuracy against NHS, NHSBSA and legislation.gov.uk guidance. Shortage information comes from official DHSC medicine supply notifications and NHS England Serious Shortage Protocols. See our editorial policy and data sources.